The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Hematology/Oncology Clinics of North America

• Publication date

  1990-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0889-8588(18)30493-3PMID 2182597
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.

  1989cited by this paper
• Detection of two alternative bcr/abl mRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction.

  1989cited by this paper
• Detection by enzymatic amplification of bcr-abl mRNA in peripheral blood and bone marrow cells of patients with chronic myelogenous leukemia.

  1989cited by this paper
• Polymerase chain reaction for detection of residual leukaemia.

  1989cited by this paper
• Mechanism of graft failure in HLA-matched and HLA-mismatched bone marrow transplant recipients.

  1989cited by this paper
• Indications for marrow transplantation in chronic myelogenous leukemia.

  1989cited by this paper
• The molecular genetics of Philadelphia chromosome-positive leukemias.

  1988cited by this paper
• T cell depletion in bone marrow transplantation.

  1988cited by this paper
• Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion.

  1988cited by this paper
• Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro.

  1988cited by this paper
• The site of the breakpoint within the bcr is a prognostic factor in Philadelphia-positive CML patients.

  1988cited by this paper
• Expression of a distinctive BCR-ABL oncogene in Ph1-positive acute lymphocytic leukemia (ALL).

  1988cited by this paper
• Cytogenetic events after bone marrow transplantation for chronic myeloid leukemia in chronic phase.

  1988cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Detection of the molecular abnormality in chronic myeloid leukemia by use of the polymerase chain reaction.

  1988cited by this paper
• Relapse after allogeneic bone marrow transplantation for Philadelphia chromosome positive chronic myeloid leukemia: cytogenetic analysis of 24 patients.

  1988cited by this paper
• Cytogenetic evolution after bone marrow transplantation for chronic myeloid leukaemia.

  1988cited by this paper
• HLA-identical marrow transplantation during accelerated-phase chronic myelogenous leukemia: analysis of survival and remission duration.

  1988cited by this paper
• Chromosome studies in patients with Philadelphia chromosome-positive chronic myeloid leukemia submitted to bone marrow transplantation--results of a European Cooperative Study.

  1987cited by this paper
• Monoclonal antibodies: their use in bone marrow transplantation.

  1987cited by this paper
• Evidence that the phl gene encodes a 160,000-dalton phosphoprotein with associated kinase activity.

  1987cited by this paper
• Complete remission after autografting for chronic myeloid leukaemia.

  1987cited by this paper
• Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.

  1987cited by this paper
• The first intron in the human c-abl gene is at least 200 kilobases long and is a target for translocations in chronic myelogenous leukemia

  1987cited by this paper
• Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.

  1987cited by this paper
• Unrelated donor bone marrow transplantation therapy for chronic myelogenous leukemia.

  1987cited by this paper
• Detection of minimal residual cells carrying the t(14;18) by DNA sequence amplification.

  1987cited by this paper
• A new fused transcript in Philadelphia chromosome positive acute lymphocytic leukaemia

  1987cited by this paper
• CML patients in blast crisis have breakpoints localized to a specific region of the BCR.

  1987cited by this paper
• Graft-versus-leukemia following bone marrow transplantation.

  1987cited by this paper
• Autografting for chronic granulocytic leukemia in transformation.

  1986cited by this paper
• bcr rearrangement in Ph-negative CML.

  1986cited by this paper
• Identical-twin (syngeneic) marrow transplantation for hematologic cancers.

  1986cited by this paper
• Bone marrow transplantation for patients with chronic myeloid leukaemia: T-cell depletion with Campath-1 reduces the incidence of graft-versus-host disease but may increase the risk of leukaemic relapse.

  1986cited by this paper
• Marrow transplantation for the treatment of chronic myelogenous leukemia.

  1986cited by this paper
• Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia.

  1986cited by this paper
• The chronic myelocytic cell line K562 contains a breakpoint in bcr and produces a chimeric bcr/c-abl transcript

  1986cited by this paper
• Autografting in chronic granulocytic leukaemia.

  1986cited by this paper
• Alternative splicing of RNAs transcribed from the human abl gene and from the bcr-abl fused gene.

  1986cited by this paper
• Characterization of natural killer cells with antileukemia activity following allogeneic bone marrow transplantation.

  1986cited by this paper
• Philadelphia‐positive metaphases in the marrow after bone marrow transplantation for chronic granulocytic leukemia

  1986cited by this paper
• Bone marrow transplantation for patients with chronic myeloid leukemia.

  1986cited by this paper
• Rearrangement in the breakpoint cluster region and the clinical course in Philadelphia-negative chronic myelogenous leukemia.

  1986cited by this paper
• Graft-versus-host disease.

  1985cited by this paper
• Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

  1985cited by this paper
• Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia.

  1985cited by this paper
• Marrow transplantation from related donors other than HLA-identical siblings.

  1985cited by this paper
• Detection of c-abl tyrosine kinase activity in vitro permits direct comparison of normal and altered abl gene products

  1985cited by this paper
• Evidence of a new chimeric bcr/c-abl mRNA in patients with chronic myelocytic leukemia and the Philadelphia chromosome.

  1985cited by this paper
• C‐abl and bcr are rearranged in a Ph1‐negative CML patient.

  1985cited by this paper
• The human cellular abl gene product in the chronic myelogenous leukemia cell line K562 has an associated tyrosine protein kinase activity.

  1985cited by this paper
• T cells and probably B cells arise from the malignant clone in chronic myelogenous leukemia.

  1985cited by this paper
• Protein-tyrosine kinases.

  1985cited by this paper
• The emerging genetics of acute lymphoblastic leukemia: clinical and biologic implications.

  1985cited by this paper
• Chronic myelogenous leukemia: is aggressive treatment indicated?

  1985cited by this paper
• Prognostic discrimination among younger patients with chronic granulocytic leukemia: relevance to bone marrow transplantation.

  1985cited by this paper
• Response of chronic myelogenous leukemia patients to COAP—splenectomy. A southwest oncology group study

  1984cited by this paper
• Autologous marrow transplantation for patients with chronic myelogenous leukemia (CML) in blast crisis

  1984cited by this paper
• ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKAEMIA

  1984cited by this paper
• Philadelphia chromosomal breakpoints are clustered within a limited region, bcr, on chromosome 22.

  1984cited by this paper
• Prognostic discrimination in "good-risk" chronic granulocytic leukemia.

  1984cited by this paper
• The early complications of bone marrow transplantation.

  1984cited by this paper
• Treatment of chronic granulocytic leukemia with chemoradiotherapy and transplantation of marrow from identical twins.

  1982cited by this paper
• Growth characteristics of leukemic and normal hematopoietic cells in Ph' + chronic myelogenous leukemia and effects of intensive treatment.

  1982cited by this paper
• A cellular oncogene is translocated to the Philadelphia chromosome in chronic myelocytic leukaemia

  1982cited by this paper
• Chromosome abnormalities in human leukemia.

  1980cited by this paper
• Ph1-positive leukaemia, including chronic myelogenous leukaemia.

  1980cited by this paper
• Results of treatment of Ph'+ chronic myelogenous leukemia with an intensive treatment regimen (L-5 protocol).

  1979cited by this paper
• Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity

  1979cited by this paper
• Disappearance of Ph1-positive cells in four patients with chronic granulocytic leukemia after chemotherapy, irradiation and marrow transplantation from an identical twin.

  1979cited by this paper
• Exclusion of chromosomal mosaicism: tables of 90%, 95% and 99% confidence limits and comments on use.

  1977cited by this paper
• Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.

  1977cited by this paper
• Bone-marrow transplantation (first of two parts).

  1975cited by this paper
• CLINICAL MANIFESTATIONS OF GRAFT‐VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL‐A-MATCHED SIBLING DONOR,S

  1974cited by this paper
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

  1973cited by this paper
• Cytogenetic studies in acute myelocytic leukemia with special emphasis on the occurrence of Ph1 chromosome.

  1970cited by this paper
• Characteristics of the terminal phase of chronic granulocytic leukemia.

  1968cited by this paper

• INVESTIGATION OF ENGRAFTMENT AND LEUKEMIA RELAPSE AFTER BONE MARROW TRANSPLANTATION, USING A VARIABLE NUMBER OF TANDEM REPEAT (VNTR) AND 6 RESTRICTION FRAGMENT LENGTH POLYMORPHISMS (RFLPs)

  2010cites this paper
• A Compounding of Errors: The Case of Bone Marrow Donation between Non-Intimate Siblings

  2006cites this paper
• Chronic Myelogenous Leukemia : A Concise Update

  2003cites this paper
• Significance of bcr-abl Gene Rearrangement Detected by Polymerase Chain Reaction After Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia

  2003cites this paper
• Second chronic phase before transplantation is crucial for improving survival of blastic phase chronic myeloid leukaemia

  2000cites this paper
• Chronic Myelogenous Leukemia (CML)

  1999cites this paper
• Interferon therapy of hematologic malignancies.

  1998cites this paper
• Intensive remission induction therapy for chronic myeloid leukemia in blast phase with a goal of post‐remission bone marrow transplant →— a pilot study

  1996cites this paper
• Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia: a metaphase‐FISH study

  1996cites this paper
• [Busulfan versus busulfan-interferon as maintenance therapy in chronic myeloid leukemia].

  1996cites this paper
• 7種の遺伝子を用いた移植骨髄細胞の生着, 白血病再発の検討 Polymerase chain reaction (PCR) 増幅断片の制限酵素切断多型を利用して

  1995cites this paper
• IFN-α で寛解導入後 little BU/CY にて骨髄移植し2年間寛解を維持している CML の 1例

  1995cites this paper
• Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia.

  1994cites this paper
• Chronic myelogenous leukemia: a concise update.

  1993cites this paper
• p 53 gene rearrangements in chronic myelocytic leukemia

  1993cites this paper
• Hematologic remission and cytogenetic improvement after treatment of stable‐phase chronic myelogenous leukemia with continuous infusion of low‐dose cytarabine

  1993cites this paper
• p53 gene rearrangements in chronic myelocytic leukemia.

  1993cites this paper
• Fractionated TBI and methotrexate-cyclosporin do not seem to increase relapses in BMT for first chronic phase CML patients: results of a single centre study.

  1992cites this paper
• Chronic leukaemias.

  1992cites this paper
• Clinical significance of bcr-abl gene rearrangement detected by polymerase chain reaction after allogeneic bone marrow transplantation in chronic myelogenous leukemia.

  1991cites this paper